Curexo Inc. (KOSDAQ:060280)
8,400.00
-90.00 (-1.06%)
Aug 14, 2025, 3:30 PM KST
Curexo Revenue
Curexo had revenue of 16.79B KRW in the quarter ending June 30, 2025, with 127.41% growth. This brings the company's revenue in the last twelve months to 27.85B, down -3.00% year-over-year. In the year 2015, Curexo had annual revenue of 27.53B with 5.33% growth.
Revenue (ttm)
27.85B
Revenue Growth
-3.00%
P/S Ratio
12.39
Revenue / Employee
960.27M
Employees
29
Market Cap
345.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2015 | 27.53B | 1.39B | 5.33% |
Dec 31, 2014 | 26.14B | -4.95B | -15.93% |
Dec 31, 2013 | 31.09B | 6.81B | 28.05% |
Dec 31, 2012 | 24.28B | 13.74B | 130.32% |
Dec 31, 2011 | 10.54B | -21.61B | -67.21% |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
Peptron | 4.30B |
SK Biopharmaceuticals | 578.00B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |